# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Zanubrutinib (BGB-3111) | BDBM250082 | IC50 | = | 379 | nM | ALA5213087 | 6.42 | nM | Homo sapiens | ||
2. | Lorlatinib | 8k, PF-06463922 | Ki | = | 53 | nM | ALA5213173 | 7.28 | nM | Homo sapiens | ||
3. | LDC1267 | 7; LDC1267 | % of control | < | 10 | % | ALA5212940 | % | Homo sapiens | |||
4. | BMS-777607 | 10, BMS-777607 | % of control | = | 0.55 | % | ALA5212882 | % | Homo sapiens | |||
5. | Dasatinib | 2, BMS-354825 | Kd | = | 0.31 | nM | ALA4419202 | 9.51 | nM | Homo sapiens | ||
6. | Motesanib | AMG-706 | Kd | = | 99 | nM | ALA4419202 | 7.00 | nM | Homo sapiens | ||
7. | Doramapimod | 45 | Kd | = | 360 | nM | ALA4419202 | 6.44 | nM | Homo sapiens | ||
8. | Pelitinib | EKB-569 | Kd | = | 190 | nM | ALA4419202 | 6.72 | nM | Homo sapiens | ||
9. | MnTMPyP pentachloride | 5 | Kd | = | 440 | nM | ALA4419202 | 6.36 | nM | Homo sapiens | ||
10. | Vandetanib | 22 | Kd | = | 480 | nM | ALA4419202 | 6.32 | nM | Homo sapiens | ||
11. | Ibrutinib (PCI-32765) | SID124898784 | IC50 | = | 79 | nM | ALA4414922 | 7.10 | nM | Homo sapiens | ||
12. | Zanubrutinib (BGB-3111) | BDBM250082 | IC50 | = | 379 | nM | ALA4414922 | 6.42 | nM | Homo sapiens | ||
13. | ALA4445335 | Roxyl-ZV-5J | INH | = | 10 | % | ALA4408109 | % | Homo sapiens | |||
14. | ALA4455923 | 48c | INH | < | 50 | % | ALA4405383 | % | Homo sapiens | |||
15. | ALA4559936 | (+/-)-6 | Activity | = | 99 | % | ALA4391358 | % | Homo sapiens | |||
16. | ALA4564973 | 50 | INH | = | 99 | % | ALA4389732 | % | Homo sapiens | |||
17. | ALA4555459 | 43 | INH | = | 96 | % | ALA4389255 | % | Homo sapiens | |||
18. | ALA4545456 | 24 | INH | = | 1.5 | % | ALA4387249 | % | Homo sapiens | |||
19. | Abemaciclib | ABEMACICLIB | INH | = | 5.5 | % | ALA4387249 | % | Homo sapiens | |||
20. | ALA4473365 | 7c | Activity | = | 5.9 | % | ALA4382536 | % | Homo sapiens |